Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SIV infection duration largely determines broadening of neutralizing antibody response in macaques
Fan Wu, Ilnour Ourmanov, Andrea Kirmaier, Sivan Leviyang, Celia LaBranche, Jinghe Huang, Sonya Whitted, Kenta Matsuda, David Montefiori, Vanessa M. Hirsch
Fan Wu, Ilnour Ourmanov, Andrea Kirmaier, Sivan Leviyang, Celia LaBranche, Jinghe Huang, Sonya Whitted, Kenta Matsuda, David Montefiori, Vanessa M. Hirsch
View: Text | PDF
Research Article AIDS/HIV Virology

SIV infection duration largely determines broadening of neutralizing antibody response in macaques

  • Text
  • PDF
Abstract

The development of broadly neutralizing antibodies (BNAbs) in HIV infection is a result of long-term coevolutionary interaction between viruses and antibodies. Understanding how this interaction promotes the increase of neutralization breadth during infection will improve the way in which AIDS vaccine strategies are designed. In this paper, we used SIV-infected rhesus macaques as a model to study the development of neutralization breadth by infecting rhesus macaques with longitudinal NAb escape variants and evaluating the kinetics of NAb response and viral evolution. We found that the infected macaques developed a stepwise NAb response against escape variants and increased neutralization breadth during the course of infection. Furthermore, the increase of neutralization breadth correlated with the duration of infection but was independent of properties of the inoculum, viral loads, or viral diversity during infection. These results imply that the duration of infection was the main factor driving the development of BNAbs. These data suggest the importance of novel immunization strategies to induce effective NAb response against HIV infection by mimicking long-term infection.

Authors

Fan Wu, Ilnour Ourmanov, Andrea Kirmaier, Sivan Leviyang, Celia LaBranche, Jinghe Huang, Sonya Whitted, Kenta Matsuda, David Montefiori, Vanessa M. Hirsch

×

Figure 1

Characterization of infectious SIVsmE660 longitudinal escape variants.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of infectious SIVsmE660 longitudinal escape variants.
(...
(A) Tiered categorization of neutralization sensitivity of SIVsmE660 variants. A heatmap was generated based on log10 values of IC50 titers and was analyzed by hierarchical clustering. The SIVsmE660 variants clustered into 4 subgroups based on their similarity in neutralization sensitivity: tier 1A (highly sensitive), tier 1B (sensitive), tier 2 (moderately resistant), and tier 3 (resistant). (B) Neutralization sensitivity of the 3 representative clones. The 3 clones were evaluated in TZM-bl neutralization assay using 6 purified polyclonal immunoglobulins from rhesus macaques chronically infected with uncloned SIVsmE660. IC50 titers are shown as dot plots and median IC50 with 95% CI are shown for each group (n = 6). Significant differences were observed between the 3 clones (P < 0.05, 1-way ANOVA). (C) Alignment of Env amino acid sequences of the 3 representative SIVsmE660 variants: SIVsmE660-FL14 (tier 1A), H807-16w-6 (tier 2), and H807-24w-4 (tier 3). Identical amino acids are shown as a dot (.), deletions are shown as a dash (–). Amino acid substitutions are shown. Potential glycosylation sites are indicated with an asterisk (*). Only domains with sequence differences are shown. (D) Replication of the 3 clones in rhesus PBMCs. PHA-stimulated rhesus PBMCs were infected with the 3 clones at an MOI of 0.001. Virus production was quantified and shown as reverse transcriptase values in supernatants collected at 3-day intervals. The experiment was performed in duplicate, and median values with 95% CI are shown. Similar virus replication was observed in PBMCs from 2 separate macaques, and the results in a representative macaque are shown. No significant difference was observed between the replication of the 3 clones (P > 0.05, 2-way ANOVA).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts